Skip to main content

ProQR Therapeutics N.V.

PRQR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001612940

In the last 90 days, ProQR Therapeutics N.V. insiders filed 4 open-market purchases and 0 sales; 70 institutions reported holding it in 13F filings for Q2 2026, worth $113.0M in total; no superinvestor holds it.

Q2 2021 vs. Q1 2021

How the institutions holding ProQR Therapeutics N.V. changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of PRQR: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders6463−1
Shares43.3M38.5M−4.84M (−11.2%)
Value$286.4M$259.4M−$27.0M (−9.4%)

New holders (20)

Institutions that held ProQR Therapeutics N.V. at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to PRQR in Q2 2021
InstitutionSharesValue% of portfolio
Rafferty Asset Management, LLC585,806$3.95M0.02%
Assenagon Asset Management S.A.532,919$3.59M0.02%
Gilder Gagnon Howe & Co LLC518,733$3.50M0.02%
Balyasny Asset Management LLC130,000$876.0K0.00%
Mirae Asset Global Investments Co., Ltd.123,083$830.0K0.00%
State Street Corp73,273$494.0K0.00%
Mitsubishi UFJ Kokusai Asset Management Co., Ltd.46,369$313.0K0.00%
Boothbay Fund Management, LLC38,408$259.0K0.01%
Pinz Capital Management, LP18,700$126.0K0.04%
Group One Trading, L.P.16,898$114.0K0.00%
Equitable Holdings, Inc.15,000$101.0K0.00%
Virtu Financial LLC13,883$94.0K0.01%
Ameriprise Financial Inc12,400$84.0K0.00%
HighPoint Advisor Group LLC10,000$67.0K0.01%
Itau Unibanco Holding S.A.6,359$43.0K0.00%
Acadian Asset Management LLC3,645$25.0K0.00%
Quadrant Capital Group LLC2,525$17.0K0.00%
US Bancorp1,663$11.0K0.00%
Signaturefd, LLC290$2.00K0.00%
Parallel Advisors, LLC191$1.00K0.00%

Sold out (21)

Institutions that held ProQR Therapeutics N.V. at the end of Q1 2021 and filed for Q2 2021 without it.